A Pilot Study of Bevacizumab-Based Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Bevacizumab (Primary) ; Irinotecan; Temozolomide
- Indications Anaplastic astrocytoma; Glioblastoma; Gliosarcoma
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 28 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Jun 2018.
- 26 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.